Using absolute risk reduction to guide the equitable distribution of COVID-19 vaccines.
18 Mar, 2022 | 09:28h | UTC
Commentary on Twitter
Using absolute risk reduction to guide the equitable distribution of COVID-19 vaccines – Analysis by Fassler et al.
What's the role of NNV?#OpenAccess
▶️ https://t.co/Bb3HlJDRXz pic.twitter.com/MPxrGNHxum
— BMJ Evidence-Based Medicine (@BMJ_EBM) March 17, 2022